Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AstraZeneca patent describes MEK inhibitors for use in cancer

July 23, 2002

Phase II Aroplatin trial enrolling in metastatic colorectal cancer

July 22, 2002

Selective PARP1/PARP2 inhibitors described by Iconix R&D team

July 22, 2002

New Tie-2 and/or VEGFR-2 inhibitors and their use in cancer

July 22, 2002

TNFerade enters phase IIb trial in advanced pancreatic cancer

July 19, 2002

Busulfex to undergo clinical evaluation in Japan in hematopoietic stem cell transplantation

July 19, 2002

Novel antineoplastic antibiotics produced by Streptomyces

July 19, 2002

Angiostatin enters phase II program

July 19, 2002

Phase II begins for irofulven + irinotecan in advanced gastrointestinal solid tumors

July 18, 2002

Procyon and Chiron extend PSP94 technology option agreement

July 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...